Detection of Pulmonary Embolism With CECT

Bracco

Status and phase: Completed; Phase 4

Conditions: Pulmonary Embolism

Treatments: Drug: Isovue

Study type: Interventional

Funder types: Industry

Identifiers

NCT00351754

IOP 106

Details and patient eligibility

About

To compare the vascular enhancement of the two contrast agents in pulmonary Multi-detector CTA

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients 18 yrs or older
• With suspected PE
• Referred for MDCTA of pulmonary arteries
• Signed informed consent

Exclusion criteria

• Pregnant and lactating females
• History of hypersensitivity to iodinated contrast agents
• Hyperthyroidism or pheochromocytoma
• Severe CHF
• Renal impairment
• Weight greater than 300 lbs
• Pacemaker
• Swan Ganz catheter
• Defibrillator or other intrathoracic metallic vascular device
• Received an investigational compound within 30 days of being in the study

Trial design

Primary purpose: Diagnostic

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind